Navigation Links
Precision Therapeutics President and CEO Sean McDonald Recognized as a Leading Business Executive and Recipient of 2010 Pacesetters Award
Date:9/22/2010

PITTSBURGH, Sept. 22 /PRNewswire/ -- Precision Therapeutics announced today that President and Chief Executive Officer Sean McDonald received the Smart Business Magazine 2010 Pacesetters Award.  The award honors thirteen regional Pacesetters and recognizes the impact of their influence in the community-at-large as well as within their own organizations. The event took place on Tuesday, September 21st at the Kean Theatre in The Washington Place, Gibsonia, Pennsylvania.  Mr. McDonald was recognized as a leader in the mid-sized company category who is setting the pace for the Pittsburgh region.

(Photo: http://photos.prnewswire.com/prnh/20100922/NE69963 )

(Photo: http://www.newscom.com/cgi-bin/prnh/20100922/NE69963 )

"Being named a Smart Business Pacesetter is such an honor for me and my team as we work toward our goal of optimizing each patient's quality of life and chance for survival by designing advanced technology that offers hope for personalized cancer treatment," said McDonald.  "It is great to see that Pittsburgh is receiving recognition as a leader in the growing life science industry and a privilege to be a part of that development."

McDonald joined Precision Therapeutics in 2001 and serves as President and CEO. Previously, Mr. McDonald founded Automated Healthcare in 1992, developing the first robotics-based solution to hospital pharmacy management.  Mr. McDonald grew the company to over $150 million in revenues when it was acquired by the McKesson Corporation in 1996.

About Precision Therapeutics

Precision Therapeutics, a life-science company based in Pittsburgh, Pennsylvania, is committed to improving outcomes of cancer patients.  As leaders in the science of individualizing cancer therapy through the use of a proprietary and unique live-tissue platform, Precision develops novel markers to help guide treatment decisions based on the biological processes of each individual's cancer.

Precision's state of the art bioinformatics combined with the analysis of the live molecular, proteomic and genomic activity of each patient's cancer offer an innovative foundation for further development and commercialization of novel predictive markers for cancer therapy.  Precision's first commercial test, ChemoFx®, is a proprietary drug response marker which measures an individual's malignant tumor response to a range of standard therapeutic alternatives under consideration by a physician.  For more information, please visit www.precisiontherapeutics.com

About Pacesetters

The Pacesetter Awards are designed to recognize business leaders in the Greater Pittsburgh Area who are setting the pace for the region.  Leaders are recognized in three divisions based on the size of their organization, its revenue and overall story of success and influence within the organization as well as the community at large.

For more information, please visit www.sbnonline.com.


'/>"/>
SOURCE Precision Therapeutics
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Clinical Experts Detail How They Use Varians TrueBeam™ Technology to Improve the Precision and Speed of Cancer Treatments
2. Applied Precisions Mobile Imaging Lab Hits the Road for a Cross-Country Journey
3. Precision Therapeutics, Inc. Named to Pittsburgh Business Times 2010 Top 100
4. Precision Bearing Technologies Featured at Atlantic Design & Manufacturing Show
5. Applied Precision Announces New Products for Life Sciences Microscopy at the 110th American Society for Microbiology Meeting in San Diego, CA, May 23-26th.
6. 96-Well Filtration Plate From Varian, Inc. Improves Sensitivity and Precision for Trace Bio-Analysis by LC/MS
7. Echo Therapeutics Initiates Needle-Free Biosensor Program for Continuous Lactate Monitoring
8. Signum Biosciences Awarded Two Additional NIH Grants for Development of Topical Therapeutics
9. CoDa Therapeutics NEXAGON® Wound Healing Gel Named to Windhovers Top 10 HOT SPACE Projects to Watch
10. Intarcia Therapeutics Names Kurt Graves Executive Chairman to Advance Strategic Interests and Broaden Commercial Goals
11. Echo Therapeutics to Present at Prestigious Accredited Members, Inc. Fall 2010 Small Cap/Micro Cap Investment Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2017)... Pa. , June 19, 2017  Researchers from ... today that they will host a live, complimentary webinar ... from the benchtop to the real world" on Wednesday ... EDT. This webinar will feature interviews ... rare look into the manipulation techniques abusers use to ...
(Date:6/14/2017)... 2017  In 2016, Embodied Labs took ... competition and came away with $25,000 in seed-fund investment. ... Forbes as "entering the life of another" and by ... "empathy to medical professionals in an entirely new dimension." ... a finalist for the Department of Education,s EdSimChallenge, where ...
(Date:6/9/2017)... 2017 AirXpanders, Inc. (ASX: AXP) (AirXpanders or ... manufacture, sale and distribution of the AeroForm® Tissue Expander ... its commercial roll-out in the United States ... one hundred (100) medical institutions and health systems, located ... needle-free alternative for women who choose reconstructive surgery following ...
Breaking Medicine Technology:
(Date:6/20/2017)... ... June 20, 2017 , ... Kenneth Mayer, MD, has been appointed a new ... Mayer, who joined the JIAS Editorial Board in 2016, has co-authored more than 800 ... Fenway Health and Co-Chair of The Fenway Institute, a member of the ...
(Date:6/20/2017)... Houston, Texas (PRWEB) , ... June 20, 2017 , ... ... of their new website and a host of new options for today’s modern ... helping seniors maintain the active, independent lifestyle they love while offering them the services ...
(Date:6/20/2017)... ... June 20, 2017 , ... MindTouch , the leading ... proud to announce Touchpoints integrations. MindTouch Touchpoints easily integrate product documentation ... to provide a seamless customer experience. , Truly “plug and play,” Touchpoints are ...
(Date:6/20/2017)... ... 20, 2017 , ... Dr. Manju R. Kejriwal currently accepts ... whether or not they have a referral. Dr. Kejriwal offers state-of-the-art treatment through ... targets bacteria and damaged tissue without affecting the surrounding tissue. This technology virtually ...
(Date:6/20/2017)... (PRWEB) , ... June 20, 2017 , ... With certifications ... Invisalign® in Denville, NJ, Drs. Adam and Hal Kimowitz are currently accepting new ... complications that traditional orthodontics can cause for some patients, which is why they offer ...
Breaking Medicine News(10 mins):